United Orthopedic Corporation (TPEX:4129)

Market Cap	10.27B
Revenue (ttm)	5.09B
Net Income (ttm)	497.37M
Shares Out	96.44M
EPS (ttm)	5.15
PE Ratio	20.68
Forward PE	n/a
Dividend	4.00 (3.72%)
Ex-Dividend Date	Jul 23, 2025

Volume	458,575
Average Volume	539,191
Open	108.00
Previous Close	107.50
Day's Range	106.00 - 109.00
52-Week Range	77.30 - 117.50
Beta	0.53
RSI	54.40
Earnings Date	Aug 12, 2025

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine produ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2024, United Orthopedic's revenue was 4.65 billion, an increase of 18.40% compared to the previous year's 3.93 billion. Earnings were 455.96 million, an increase of 20.11%.